Most of what is written about funding a buy-sell obligation assumes death as the trigger and life insurance as the answer. A shareholders' agreement usually obligates a buyout on other events too — retirement, disability, deadlock, a shareholder simply wanting out — and insurance was never designed to fund most of them. This is what actually pays for those buyouts, and what it costs the company to do it.
Key takeaways
SECTION 01 OF 05
Life insurance solves the buy-sell funding problem efficiently for exactly one trigger: the death of an owner, which an insurer will underwrite and price. See funding a buy-sell obligation with insurance for how the cross-purchase and corporate-redemption structures work when that coverage exists. Retirement is scheduled, not insurable; disability coverage is narrower and usually smaller than a full buyout would need; and a voluntary exit or a shareholder dispute is not an insurable event at all. A shareholders’ agreement that only addresses the death trigger has, in practice, left every other exit unfunded.
SECTION 02 OF 05
Absent insurance, the company itself typically redeems the departing owner’s shares, usually for a promissory note rather than cash, because the cash to pay the full price outright rarely exists on the day it is owed. The note’s interest rate, term and security become the real negotiation, and a departing owner who is also a creditor of the company they used to run is taking on a very different risk than one who was paid out from an insurance policy the day they died.
SECTION 03 OF 05
A corporation cannot buy back its own shares if there are reasonable grounds for believing the payment would leave it unable to pay its liabilities as they become due, or that the realizable value of its assets would then be less than the total of its liabilities and stated capital of all classes — the limitation is written directly into the corporate statute governing the redemption. A profitable, growing company can still fail this test if the buyout is large relative to its balance sheet, which is exactly when the promissory-note structure above becomes unavoidable rather than a choice.
SECTION 04 OF 05
Where a corporation redeems, acquires or cancels its own shares, the amount paid in excess of the shares’ paid-up capital is deemed to be a dividend paid by the corporation and received by the departing shareholder — not a capital gain, and not eligible for the lifetime capital gains exemption. Treadstone Law's comparison of cross-purchase and corporate-redemption structures covers the same distinction on the funded side; the unfunded case makes the choice of structure matter more, not less, because the dividend result is now competing against a cash-flow problem the corporation cannot simply insure its way out of.
SECTION 05 OF 05
A shareholders’ agreement that specifies a valuation formula and a death trigger but says nothing about how a retirement or a voluntary exit gets funded has not solved this problem, it has deferred it to the day someone actually leaves — see what happens when the agreement has no retirement trigger at all for what happens when there is no mechanism at all, not just no funding for the one that exists. This is background for the conversation, not a substitute for it — Treadstone is an AI consulting firm, not a law firm or an accounting practice, and the specific numbers and elections below belong to your own accountant and an estates or corporate lawyer working from your actual figures.
Not really. Insurance works efficiently for the one trigger an insurer will underwrite — death. Retirement is scheduled rather than insurable, and a voluntary exit or dispute is not an insurable event at all, so those buyouts are usually left unfunded.
Yes. A corporation cannot buy back its own shares if there are reasonable grounds to believe the payment would leave it unable to pay its debts, or that its assets would then fall short of its liabilities and stated capital — a legal ceiling, not just a cash-flow constraint.
No. The amount paid in excess of the shares’ paid-up capital is deemed to be a dividend under ITA section 84(3), not a capital gain — a materially different tax result that does not qualify for the lifetime capital gains exemption at all.
Sources
Canadian small-business transaction data is not published anywhere, so most valuations in this country quote an American benchmark. The Deavo–Treadstone Acquisition Index is a daily record of Canadian listings built to replace that: asking-price distributions by province and city are published now, and days on market, departure rates and asking-to-sale spreads follow as the series lengthens. Leave an email and we will tell you as each measure lands.
No pitch, no listings. One email when the first report lands.
